Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...

Hims & Hers Health ( HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...

If you’ve recently stopped taking semaglutide—commonly known by brand names like Ozempic or Wegovy—you may be wondering how to transition back to normal while maintaining your health and weight.

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

Obese adults who took the weekly injection lost up to 22% of their starting weight after 11 months — compared to just 14% over 15 months for semaglutide, the active ingredient in Ozempic and Wegovy.

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

incorrect amounts of semaglutide or harmful additives. Ozempic costs $381 less per month than Wegovy if you pay full price. And you're more likely to get insurance to cover Ozempic than Wegovy.

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...